Translational Medicine: Strategies and Statistical MethodsDennis Cosmatos, Shein-Chung Chow CRC Press, 17 Des 2008 - 224 halaman Examines Critical Decisions for Transitioning Lab Science to a Clinical SettingThe development of therapeutic pharmaceutical compounds is becoming more expensive, and the success rates for getting such treatments approved for marketing and to the patients is decreasing. As a result, translational medicine (TM) is becoming increasingly important in |
Isi
| 1 | |
Chapter 2 Strategic Concepts in Translational Medicine | 9 |
Chapter 3 Design and Analysis Approaches for Discovery Translational Medicine | 33 |
Chapter 4 Biomarker Development | 75 |
Chapter 5 Targeted Clinical Trials | 93 |
Chapter 6 Statistical Methods in Translational Medicine | 119 |
Chapter 7 Nonparametric Methods in Translational Research | 147 |
Edisi yang lain - Lihat semua
Translational Medicine: Strategies and Statistical Methods Dennis Cosmatos,Shein-Chung Chow Pratinjau tidak tersedia - 2019 |
Translational Medicine: Strategies and Statistical Methods Dennis Cosmatos,Shein-Chung Chow Pratinjau tidak tersedia - 2008 |
Istilah dan frasa umum
absolute change Adaptive Design adjuvant Allele analysis analyte antibody assays assessment asymptotic BioGenex InSite Her-2/neu biomarker bootstrap breast cancer bridging studies calibration chemotherapy clinical data clinical endpoint clinical outcome clinical studies clinical trials compound confidence interval criteria curve decision detection device diagnostic discovery disease distant metastasis distribution dose selection efficacy erlotinib estimate evaluation example factors gefitinib gene expression genomic genotyping given hazard ratio HER2 HER2 gene Herceptin human imatinib mesylate immunoassays linear lost in translation MammaPrint marker measure metastasis methods microarray molecular targets nonparametric null hypothesis observed Oncotype original region over-expression p-value parameters patient population pharmaceutical phase preclinical predictive prognostic quantitative randomized response safety sample score Shao standard study endpoint Table Taiwan targeted clinical trials therapy tion Translational Medicine translational process trastuzumab treatment effect true endpoint tumor U.S. FDA validation variable versus